Antibody-based technique holds promise for children in "bubbles"

09/2/2009 | BBC

U.K. doctors have developed a technique that could eliminate the need for chemotherapy drugs to administer a bone marrow transplant in children suffering from primary immunodeficiencies, or genetic disorders affecting the immune system, and who must live in "bubbles," or sterile environments. The treatment uses an antibody, which homes in on a molecule linked to blood and bone cells, to wipe out a patient's bone marrow and provide space for donor stem cells.

View Full Article in:

BBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC